Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto -2020/21 parent results

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            101.01          106.48                                
                 (-5.1 pct)      (+2.0 pct)                              
  Operating         13.02           13.26                                
                 (-1.9 pct)      (+1.9 pct)                              
  Recurring         12.56           14.37                                
                 (-12.6 pct)     (-5.4 pct)                              
  Net                8.92            6.98                                
                 (+27.8 pct)     (+44.9 pct)                             
  EPS             78.20 yen       61.19 yen                              
  EPS Diluted     77.97 yen       61.00 yen                              
  Ann Div         28.00 yen       26.00 yen      30.00 yen               
  -Q2 Div         13.00 yen       13.00 yen      15.00 yen               
  -Q4 Div         15.00 yen       13.00 yen      15.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news